0 participants
A Trial of CDX-1401 in Combination With Poly-ICLC and Pembrolizumab, in Previously Treated Advanced Solid Tumor Patients
- Study Type:
- INTERVENTIONAL
- Last Updated:
- 2016-12-07
- Start Date:
- 2017-01-31
- Completion:
- 2018-07-31
Conditions
- Non Small Cell Lung Cancer
- Advanced Triple Negative Breast Cancer
- Small Cell Lung Cancer
- Urothelial Cancer
- Mesothelioma
- Malignant Melanoma
Interventions
- DRUG
- BIOLOGICAL
No Results Yet